GlaxoSmithKline News and Research

RSS

Social and economic disadvantage may explain the higher risk of dementia in women

A large international study of dementia risk involving almost 30,000 people from 18 countries covering all six continents suggests that social and economic disadvantage may explain the higher risk of the condition in women.

15 Feb 2023

New screening tool shows promise to help primary care physicians identify COPD

Researchers at National Jewish Health and colleagues across the country have partnered to develop a screening tool to help primary care physicians identify chronic obstructive pulmonary disease (COPD).

14 Feb 2023

Multi-country study examines clinical and community antibiotic use during the pandemic

Globally, during the first two years of the COVID-19 pandemic, antibiotics were prescribed to 75 percent of COVID-19 patients despite bacterial coinfection rates averaging less than 10 percent.

6 Feb 2023

Researchers discover mechanism underlying the development and intensification of cancer treatment-related pain

A combination of chemotherapy and drugs that stimulate the immune system to combat cancer is increasingly used to control progression of the disease in patients.

30 Jan 2023

Newly revised classification tool for standardized diagnostic reporting of melanocytic lesions

With the growing number of skin biopsies performed annually for suspected melanoma, a simple, easily understood standardized classification system for melanocytic lesions is increasingly important to aid pathologists and clinicians who examine millions of tissue samples each year and to alleviate patient confusion and anxiety.

11 Jan 2023

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the neoadjuvant setting had an overall response rate of 75 percent in the absence of anastrozole and 63 percent in combination with anastrozole, according to results from the phase II TRIO-US B-12 TALENT trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

Shingles linked with higher long-term risk of major cardiovascular event

A new study by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, demonstrated that shingles, also known as herpes zoster, is associated with an almost 30% higher long-term risk of a major cardiovascular event such a stroke or heart attack.

22 Nov 2022

Cancer Research Horizons: The Innovation Engine of Cancer Research UK

Following ELRIG 2022, News-Medical speaks with Cancer Research Horizons, the innovation engine of Cancer Research UK about their efforts to advance the drug discovery sector.

From Cancer Research UK 14 Nov 2022

New program leverages digital solutions to improve patients' blood pressure and cholesterol levels

Heart disease is the leading cause of death in the United States and around the world. Lowering high blood pressure and cholesterol could help to reduce morbidity and mortality, but frequent in-person visits to measure and manage these readouts can be a burden for patients.

9 Nov 2022

Study finds new drug combination to be more effective against complicated urinary tract infections

An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially against stubborn, drug-resistant infections.

25 Oct 2022

Researchers discover how cancer cells can turn off the immune system to help tumors grow

When cancer arises in the body, it starts with tumor cells that rapidly grow and divide and eventually spread.

29 Sep 2022

Most people infected with SARS-CoV2 recover within 12 months, study finds

A McMaster University-led study has found that most people infected with the SARS-CoV2 virus recover within 12 months, irrespective of the severity.

22 Sep 2022

COVID-19 during pregnancy damages the placenta's immune response to further infections

If a woman contracts COVID-19 during her pregnancy, the infection, even if it's mild, damages the placenta's immune response to further infections, a UW Medicine-led study has found.

19 Sep 2022

R21/Matrix-M booster maintains high efficacy against first and multiple episodes of clinical malaria

The phase 1/2b clinical trial on R21/Matrix-M malaria vaccine has recently reported the safety and efficacy of booster vaccination at 12 months.

15 Sep 2022

Targeting the Notch pathway with gamma secretase inhibitor improves outcomes in patients with rare cancers

Significant improvement in progression-free survival and response rate combined with reduced symptoms and better quality of life are reported as outcomes of a new treatment approach for patients with desmoid tumors, which are benign, but locally aggressive and invasive soft tissue tumors.

12 Sep 2022

Novel tests detect common cancer signals across over 50 types of cancer

Cancer doctors, care providers and payers need to get ready for a major shift in early cancer detection that will affect almost every stage of cancer diagnosis and treatment. New data supporting the accuracy of multi-cancer early detection (MCED) blood testing (1), presented at the ESMO Congress 2022, have major implications for future cancer care provision, said Fabrice André, ESMO 2022 Scientific Co-Chair.

12 Sep 2022

Pollutant particles in the air trigger lung cancer in non-smokers

A new mechanism has been identified through which very small pollutant particles in the air may trigger lung cancer in people who have never smoked, paving the way to new prevention approaches and development of therapies, according to late-breaking data [to be] reported at the ESMO Congress 2022 by scientists of the Francis Crick Institute and University College London, funded by Cancer Research UK. The particles, which are typically found in vehicle exhaust and smoke from fossil fuels, are associated with non-small cell lung cancer (NSCLC) risk, accounting for over 250,000 lung cancer deaths globally per year.

12 Sep 2022

GlaxoSmithKline News and Research

Social and economic disadvantage may explain the higher risk of dementia in women

New screening tool shows promise to help primary care physicians identify COPD

Multi-country study examines clinical and community antibiotic use during the pandemic

Researchers discover mechanism underlying the development and intensification of cancer treatment-related pain

Newly revised classification tool for standardized diagnostic reporting of melanocytic lesions

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Shingles linked with higher long-term risk of major cardiovascular event

Cancer Research Horizons: The Innovation Engine of Cancer Research UK

New program leverages digital solutions to improve patients' blood pressure and cholesterol levels

Study finds new drug combination to be more effective against complicated urinary tract infections

Researchers discover how cancer cells can turn off the immune system to help tumors grow

Most people infected with SARS-CoV2 recover within 12 months, study finds

COVID-19 during pregnancy damages the placenta's immune response to further infections

R21/Matrix-M booster maintains high efficacy against first and multiple episodes of clinical malaria

Targeting the Notch pathway with gamma secretase inhibitor improves outcomes in patients with rare cancers

Novel tests detect common cancer signals across over 50 types of cancer

Pollutant particles in the air trigger lung cancer in non-smokers

Newly discovered protein could help to improve fertility treatments

Triplet therapy slows progression of advanced kidney cancer

Study: Number of babies born with cytomegalovirus decreased during the COVID-19 pandemic

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News